Scala Biodesign’s software platform enables one-shot protein optimization by enhancing expression and stability, improving enzyme activity and optimizing therapeutic antibodies.
בהובלת Grove Ventures
31 במרץ 2026
מקורכותרות אחרונות מגלובס ומכלכליסט שמזכירות את החברה.
כלכליסט · 31 במרץ 2026
Back to all positions Tel Aviv · Hybrid · Full-time Senior Applied AI Researcher Develop cutting-edge AI methods to design and optimize antibodies, advancing therapeutic programs…
Back to all positions Tel Aviv · Hybrid · Full-time Marketing Lead Build and execute Scala's marketing function, turning breakthrough technology into commercial momentum. Apply…
